UK medical cannabis operator Kanabo Group has fallen into administration, seeing the last remaining member of the first four cannabis pioneers onto the London Stock Exchange face collapse.
CELLULAR Goods (LSE: CBX), a UK-based wellness company providing premium consumer products formulated with lab-produced cannabinoids, today announces the publication of a new white paper, ‘The 5 A’s of Cannabinoid Skincare’, which explores the benefits cannabinoids, namely cannabidiol (CBD) and cannabigerol (CBG), can have for the skin as powerhouse ingredients that provide a multitude of…
THIS week has seen European cannabis stocks once again gain momentum in the face of dismal economic news.
CELLULAR Goods (LSE: CBX), a UK-based wellness company providing premium consumer products formulated with lab-produced cannabinoids, is pleased to announce the appointment of Bruna Nikolla as Chief Financial Officer.
In further signs of positive momentum, UK listed cannabis stocks made an unexpected comeback this week, following months of unrelenting share price losses across Europe.
CELLULAR Goods has released its first significant update since announcing that its ingestibles products were not legally allowed to be sold in the UK.
THE fallout from the publication of the FSA’s Public List is continuing to be felt on the stock markets this week, with the regulator issuing a ‘final call’ for evidence after a number of CBD companies came forward with ‘new evidence linking large numbers of individual products to applications.’
European cannabis stocks had another generally positive week last week, with some major announcements from the North American market prop-up gains across the continent.
FEBRUARY 2022 marked the one-year anniversary of MGC Pharmaceuticals IPO on the London Stock Exchange, which saw cannabis stocks traded on the platform for the first time in its 320-year history.
